- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.50 Å
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 6 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 2 x 6PE: 1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(Non-covalent)
6PE.2: 9 residues within 4Å:- Chain A: S.438, F.441, L.443
- Chain C: H.220, I.225
- Chain D: M.221, K.225
- Ligands: CDL.4, PX4.19
7 PLIP interactions:1 interactions with chain D, 3 interactions with chain A, 3 interactions with chain C- Hydrophobic interactions: D:K.225, A:L.443
- Hydrogen bonds: A:S.438, A:F.441, C:T.224
- Salt bridges: C:H.220, C:H.220
6PE.28: 9 residues within 4Å:- Chain K: S.438, F.441, L.443
- Chain M: H.220, I.225
- Chain N: M.221, K.225
- Ligands: CDL.30, PX4.45
7 PLIP interactions:3 interactions with chain K, 3 interactions with chain M, 1 interactions with chain N- Hydrophobic interactions: K:L.443, N:K.225
- Hydrogen bonds: K:S.438, K:F.441, M:T.224
- Salt bridges: M:H.220, M:H.220
- 18 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.3: 7 residues within 4Å:- Chain A: D.331, Q.429, L.430, P.431, D.432
- Chain C: P.218
- Chain G: F.3
Ligand excluded by PLIPPO4.5: 3 residues within 4Å:- Chain A: S.290
- Chain B: R.66
- Chain P: A.98
Ligand excluded by PLIPPO4.14: 6 residues within 4Å:- Chain C: G.166, F.167, S.168
- Chain O: V.68, M.71, R.92
Ligand excluded by PLIPPO4.16: 2 residues within 4Å:- Chain D: E.123, R.190
Ligand excluded by PLIPPO4.20: 5 residues within 4Å:- Chain E: R.15, P.16, E.17
- Chain G: R.23
- Ligands: PO4.24
Ligand excluded by PLIPPO4.23: 3 residues within 4Å:- Chain F: P.41, Y.83
- Chain L: R.113
Ligand excluded by PLIPPO4.24: 4 residues within 4Å:- Chain G: R.23, A.24, F.25
- Ligands: PO4.20
Ligand excluded by PLIPPO4.25: 5 residues within 4Å:- Chain G: F.25, H.27, Y.28, F.29, S.30
Ligand excluded by PLIPPO4.26: 3 residues within 4Å:- Chain G: A.42, L.45, R.46
Ligand excluded by PLIPPO4.29: 7 residues within 4Å:- Chain K: D.331, Q.429, L.430, P.431, D.432
- Chain M: P.218
- Chain Q: F.3
Ligand excluded by PLIPPO4.31: 3 residues within 4Å:- Chain F: A.98
- Chain K: S.290
- Chain L: R.66
Ligand excluded by PLIPPO4.40: 6 residues within 4Å:- Chain E: V.68, M.71, R.92
- Chain M: G.166, F.167, S.168
Ligand excluded by PLIPPO4.42: 2 residues within 4Å:- Chain N: E.123, R.190
Ligand excluded by PLIPPO4.46: 5 residues within 4Å:- Chain O: R.15, P.16, E.17
- Chain Q: R.23
- Ligands: PO4.50
Ligand excluded by PLIPPO4.49: 3 residues within 4Å:- Chain B: R.113
- Chain P: P.41, Y.83
Ligand excluded by PLIPPO4.50: 4 residues within 4Å:- Chain Q: R.23, A.24, F.25
- Ligands: PO4.46
Ligand excluded by PLIPPO4.51: 5 residues within 4Å:- Chain Q: F.25, H.27, Y.28, F.29, S.30
Ligand excluded by PLIPPO4.52: 3 residues within 4Å:- Chain Q: A.42, L.45, R.46
Ligand excluded by PLIP- 8 x CDL: CARDIOLIPIN(Non-covalent)
CDL.4: 9 residues within 4Å:- Chain A: F.335, W.442, L.443, R.444
- Chain C: R.4, F.17, I.18, H.220
- Ligands: 6PE.2
5 PLIP interactions:3 interactions with chain C, 2 interactions with chain A- Hydrophobic interactions: C:F.17
- Salt bridges: C:R.4, C:H.220, A:R.444
- Hydrogen bonds: A:L.443
CDL.11: 11 residues within 4Å:- Chain C: S.27, S.28, W.29, M.95
- Chain F: Q.62
- Chain G: V.36, R.39, T.40, C.43
- Ligands: PEE.12, CDL.17
7 PLIP interactions:4 interactions with chain G, 2 interactions with chain C, 1 interactions with chain F- Hydrophobic interactions: G:T.40
- Salt bridges: G:R.39, G:R.39, G:R.39
- Hydrogen bonds: C:S.28, C:S.28, F:Q.62
CDL.17: 22 residues within 4Å:- Chain C: S.28, N.31, L.35, K.226, L.229, G.230, L.233, L.234
- Chain D: Y.219, K.222, R.223, K.230
- Chain F: R.61, Q.62
- Chain G: Y.28, F.29, G.32, I.33, N.35, V.36, R.39
- Ligands: CDL.11
15 PLIP interactions:5 interactions with chain C, 3 interactions with chain G, 7 interactions with chain D- Hydrophobic interactions: C:L.35, C:L.233, C:L.233, G:I.33, D:Y.219, D:Y.219
- Hydrogen bonds: C:N.31, G:N.35, D:K.230, D:K.230
- Salt bridges: C:K.226, G:R.39, D:K.222, D:R.223, D:K.230
CDL.22: 8 residues within 4Å:- Chain E: K.52, S.56, V.59, S.60, S.63
- Chain M: Y.154, N.158, W.162
8 PLIP interactions:6 interactions with chain E, 2 interactions with chain M- Hydrogen bonds: E:S.56, E:S.56, E:S.63, M:N.158
- Salt bridges: E:K.52, E:K.52, E:K.52
- Hydrophobic interactions: M:Y.154
CDL.30: 9 residues within 4Å:- Chain K: F.335, W.442, L.443, R.444
- Chain M: R.4, F.17, I.18, H.220
- Ligands: 6PE.28
5 PLIP interactions:2 interactions with chain K, 3 interactions with chain M- Hydrogen bonds: K:L.443
- Salt bridges: K:R.444, M:R.4, M:H.220
- Hydrophobic interactions: M:F.17
CDL.37: 11 residues within 4Å:- Chain M: S.27, S.28, W.29, M.95
- Chain P: Q.62
- Chain Q: V.36, R.39, T.40, C.43
- Ligands: PEE.38, CDL.43
7 PLIP interactions:4 interactions with chain Q, 1 interactions with chain P, 2 interactions with chain M- Hydrophobic interactions: Q:T.40
- Salt bridges: Q:R.39, Q:R.39, Q:R.39
- Hydrogen bonds: P:Q.62, M:S.28, M:S.28
CDL.43: 22 residues within 4Å:- Chain M: S.28, N.31, L.35, K.226, L.229, G.230, L.233, L.234
- Chain N: Y.219, K.222, R.223, K.230
- Chain P: R.61, Q.62
- Chain Q: Y.28, F.29, G.32, I.33, N.35, V.36, R.39
- Ligands: CDL.37
16 PLIP interactions:8 interactions with chain N, 3 interactions with chain Q, 5 interactions with chain M- Hydrophobic interactions: N:Y.219, N:Y.219, Q:I.33, M:L.35, M:L.233, M:L.233
- Hydrogen bonds: N:Y.219, N:K.230, N:K.230, Q:N.35, M:N.31
- Salt bridges: N:K.222, N:R.223, N:K.230, Q:R.39, M:K.226
CDL.48: 8 residues within 4Å:- Chain C: Y.154, N.158, W.162
- Chain O: K.52, S.56, V.59, S.60, S.63
8 PLIP interactions:6 interactions with chain O, 2 interactions with chain C- Hydrogen bonds: O:S.56, O:S.56, O:S.63, C:N.158
- Salt bridges: O:K.52, O:K.52, O:K.52
- Hydrophobic interactions: C:Y.154
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
HEM.6: 25 residues within 4Å:- Chain C: L.40, Q.43, I.44, G.47, L.48, L.50, A.51, Y.54, V.65, R.79, H.82, A.83, A.86, F.89, T.125, A.126, G.129, Y.130, L.132, P.133, F.178, H.181, F.182, P.185, Y.272
21 PLIP interactions:21 interactions with chain C,- Hydrophobic interactions: C:L.40, C:Q.43, C:I.44, C:L.50, C:Y.54, C:A.83, C:F.89, C:T.125, C:A.126, C:L.132, C:L.132, C:F.178, C:F.182, C:F.182
- Salt bridges: C:R.79, C:R.79
- pi-Stacking: C:H.82, C:H.181
- pi-Cation interactions: C:H.82
- Metal complexes: C:H.82, C:H.181
HEM.7: 24 residues within 4Å:- Chain C: W.30, G.33, S.34, L.36, G.37, F.89, L.93, H.96, V.97, R.99, S.105, F.108, T.111, W.112, G.115, V.116, L.118, L.119, H.195, L.196, L.199, S.204, N.205
- Ligands: JAG.13
21 PLIP interactions:21 interactions with chain C,- Hydrophobic interactions: C:L.36, C:F.89, C:V.97, C:T.111, C:W.112, C:W.112, C:L.119, C:L.196, C:L.199, C:L.199
- Hydrogen bonds: C:G.33, C:S.105, C:N.205
- Water bridges: C:W.30, C:F.32
- Salt bridges: C:H.96, C:R.99, C:R.99
- pi-Cation interactions: C:R.99
- Metal complexes: C:H.96, C:H.195
HEM.32: 25 residues within 4Å:- Chain M: L.40, Q.43, I.44, G.47, L.48, L.50, A.51, Y.54, V.65, R.79, H.82, A.83, A.86, F.89, T.125, A.126, G.129, Y.130, L.132, P.133, F.178, H.181, F.182, P.185, Y.272
21 PLIP interactions:21 interactions with chain M,- Hydrophobic interactions: M:L.40, M:Q.43, M:I.44, M:L.50, M:Y.54, M:A.83, M:F.89, M:T.125, M:A.126, M:L.132, M:L.132, M:F.178, M:F.182, M:F.182
- Salt bridges: M:R.79, M:R.79
- pi-Stacking: M:H.82, M:H.181
- pi-Cation interactions: M:H.82
- Metal complexes: M:H.82, M:H.181
HEM.33: 24 residues within 4Å:- Chain M: W.30, G.33, S.34, L.36, G.37, F.89, L.93, H.96, V.97, R.99, S.105, F.108, T.111, W.112, G.115, V.116, L.118, L.119, H.195, L.196, L.199, S.204, N.205
- Ligands: JAG.39
21 PLIP interactions:21 interactions with chain M,- Hydrophobic interactions: M:L.36, M:F.89, M:V.97, M:T.111, M:W.112, M:W.112, M:L.119, M:L.196, M:L.199, M:L.199
- Hydrogen bonds: M:G.33, M:S.105, M:N.205
- Water bridges: M:W.30, M:F.32
- Salt bridges: M:H.96, M:R.99, M:R.99
- pi-Cation interactions: M:R.99
- Metal complexes: M:H.96, M:H.195
- 2 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
LMT.8: 5 residues within 4Å:- Chain C: H.344, I.347, T.348, Q.351
- Chain G: E.64
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:Q.351, C:Q.351
- Salt bridges: C:H.344
LMT.34: 5 residues within 4Å:- Chain M: H.344, I.347, T.348, Q.351
- Chain Q: E.64
4 PLIP interactions:4 interactions with chain M- Hydrogen bonds: M:T.348, M:Q.351, M:Q.351
- Salt bridges: M:H.344
- 4 x PEE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)
PEE.12: 17 residues within 4Å:- Chain C: W.29, Y.94, M.95, G.98, L.101, Y.102, Y.103, M.315, Q.321, F.324, W.325, V.328, L.331
- Chain F: Q.62
- Chain G: C.43, V.47
- Ligands: CDL.11
16 PLIP interactions:15 interactions with chain C, 1 interactions with chain F- Hydrophobic interactions: C:W.29, C:W.29, C:W.29, C:L.101, C:Y.102, C:Y.102, C:Y.103, C:F.324, C:W.325, C:W.325, C:V.328, C:L.331
- Hydrogen bonds: C:Y.102, C:Y.102, C:Q.321, F:Q.62
PEE.21: 10 residues within 4Å:- Chain C: I.77
- Chain D: H.199, M.203, K.206, M.207, M.210
- Chain E: Y.49, N.53, Q.57
- Chain J: D.35
5 PLIP interactions:3 interactions with chain D, 1 interactions with chain E, 1 interactions with chain J- Hydrophobic interactions: D:M.210
- Salt bridges: D:H.199, D:K.206
- Hydrogen bonds: E:Q.57, J:D.35
PEE.38: 17 residues within 4Å:- Chain M: W.29, Y.94, M.95, G.98, L.101, Y.102, Y.103, M.315, Q.321, F.324, W.325, V.328, L.331
- Chain P: Q.62
- Chain Q: C.43, V.47
- Ligands: CDL.37
16 PLIP interactions:15 interactions with chain M, 1 interactions with chain P- Hydrophobic interactions: M:W.29, M:W.29, M:W.29, M:L.101, M:Y.102, M:Y.102, M:Y.103, M:F.324, M:W.325, M:W.325, M:V.328, M:L.331
- Hydrogen bonds: M:Y.102, M:Y.103, M:Q.321, P:Q.62
PEE.47: 10 residues within 4Å:- Chain M: I.77
- Chain N: H.199, M.203, K.206, M.207, M.210
- Chain O: Y.49, N.53, Q.57
- Chain T: D.35
5 PLIP interactions:3 interactions with chain N, 1 interactions with chain T, 1 interactions with chain O- Hydrophobic interactions: N:M.210
- Salt bridges: N:H.199, N:K.206
- Hydrogen bonds: T:D.35, O:Q.57
- 2 x JAG: 2-methyl-3-[4-[4-(trifluoromethyloxy)phenoxy]phenyl]-5,6,7,8-tetrahydro-3~{H}-quinolin-4-one(Non-covalent)
JAG.13: 14 residues within 4Å:- Chain C: A.16, F.17, L.20, I.26, S.34, G.37, M.189, M.193, L.196, H.200, S.204, F.219, D.227
- Ligands: HEM.7
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:F.17, C:F.17, C:L.20, C:I.26, C:L.196, C:F.219, C:F.219
- pi-Stacking: C:F.219
JAG.39: 14 residues within 4Å:- Chain M: A.16, F.17, L.20, I.26, S.34, G.37, M.189, M.193, L.196, H.200, S.204, F.219, D.227
- Ligands: HEM.33
8 PLIP interactions:8 interactions with chain M- Hydrophobic interactions: M:F.17, M:F.17, M:L.20, M:I.26, M:L.196, M:F.219, M:F.219
- pi-Stacking: M:F.219
- 2 x HEC: HEME C(Non-covalent)
HEC.15: 22 residues within 4Å:- Chain D: V.31, V.35, C.36, C.39, H.40, N.104, A.107, L.108, P.109, P.110, L.112, I.115, R.119, Y.125, V.126, L.129, L.130, F.152, I.157, G.158, M.159, P.162
17 PLIP interactions:17 interactions with chain D,- Hydrophobic interactions: D:V.31, D:V.35, D:N.104, D:A.107, D:P.109, D:P.110, D:L.112, D:I.115, D:V.126, D:L.129, D:L.130, D:P.162
- Hydrogen bonds: D:Y.125, D:Y.125, D:G.158
- Salt bridges: D:R.119
- Metal complexes: D:H.40
HEC.41: 22 residues within 4Å:- Chain N: V.31, V.35, C.36, C.39, H.40, N.104, A.107, L.108, P.109, P.110, L.112, I.115, R.119, Y.125, V.126, L.129, L.130, F.152, I.157, G.158, M.159, P.162
16 PLIP interactions:16 interactions with chain N,- Hydrophobic interactions: N:V.31, N:V.35, N:N.104, N:A.107, N:P.109, N:P.110, N:L.112, N:I.115, N:V.126, N:L.129, N:L.130, N:P.162
- Hydrogen bonds: N:Y.125, N:G.158
- Salt bridges: N:R.119
- Metal complexes: N:H.40
- 2 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
FES.18: 9 residues within 4Å:- Chain E: C.139, H.141, L.142, C.144, C.158, C.160, H.161, S.163, P.175
2 PLIP interactions:2 interactions with chain E,- Metal complexes: E:H.141, E:C.158
FES.44: 9 residues within 4Å:- Chain O: C.139, H.141, L.142, C.144, C.158, C.160, H.161, S.163, P.175
2 PLIP interactions:2 interactions with chain O,- Metal complexes: O:H.141, O:C.158
- 2 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PX4.19: 16 residues within 4Å:- Chain A: Y.415, D.416, F.441, L.443
- Chain D: M.221
- Chain E: Y.37, T.40, T.44, V.47
- Chain J: F.13, R.14, T.16, F.19, A.20, I.23
- Ligands: 6PE.2
8 PLIP interactions:2 interactions with chain A, 3 interactions with chain E, 3 interactions with chain J- Salt bridges: A:D.416
- pi-Cation interactions: A:F.441, E:Y.37, J:F.19
- Hydrophobic interactions: E:V.47, J:A.20, J:I.23
- Hydrogen bonds: E:T.40
PX4.45: 16 residues within 4Å:- Chain K: Y.415, D.416, F.441, L.443
- Chain N: M.221
- Chain O: Y.37, T.40, T.44, V.47
- Chain T: F.13, R.14, T.16, F.19, A.20, I.23
- Ligands: 6PE.28
7 PLIP interactions:3 interactions with chain T, 2 interactions with chain O, 2 interactions with chain K- Hydrophobic interactions: T:A.20, T:I.23, O:V.47
- pi-Cation interactions: T:F.19, O:Y.37, K:F.441
- Salt bridges: K:D.416
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McPhillie, M.J. et al., Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites. Front Cell Infect Microbiol (2020)
- Release Date
- 2020-07-22
- Peptides
- Cytochrome b-c1 complex subunit 1, mitochondrial: AK
Cytochrome b-c1 complex subunit 2, mitochondrial: BL
Cytochrome b: CM
Cytochrome c1, heme protein, mitochondrial: DN
Cytochrome b-c1 complex subunit Rieske, mitochondrial: EO
Cytochrome b-c1 complex subunit 7: FP
Cytochrome b-c1 complex subunit 8: GQ
Cytochrome b-c1 complex subunit 6, mitochondrial: HR
Cytochrome b-c1 complex subunit Rieske, mitochondrial: IS
Cytochrome b-c1 complex subunit 9: JT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AK
AB
BL
BC
CM
CD
DN
DE
EO
EF
FP
FG
GQ
GH
HR
HI
IS
IJ
JT
J - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.50 Å
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 6 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 2 x 6PE: 1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(Non-covalent)
- 18 x PO4: PHOSPHATE ION(Non-functional Binders)
- 8 x CDL: CARDIOLIPIN(Non-covalent)
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 4 x PEE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)
- 2 x JAG: 2-methyl-3-[4-[4-(trifluoromethyloxy)phenoxy]phenyl]-5,6,7,8-tetrahydro-3~{H}-quinolin-4-one(Non-covalent)
- 2 x HEC: HEME C(Non-covalent)
- 2 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 2 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McPhillie, M.J. et al., Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites. Front Cell Infect Microbiol (2020)
- Release Date
- 2020-07-22
- Peptides
- Cytochrome b-c1 complex subunit 1, mitochondrial: AK
Cytochrome b-c1 complex subunit 2, mitochondrial: BL
Cytochrome b: CM
Cytochrome c1, heme protein, mitochondrial: DN
Cytochrome b-c1 complex subunit Rieske, mitochondrial: EO
Cytochrome b-c1 complex subunit 7: FP
Cytochrome b-c1 complex subunit 8: GQ
Cytochrome b-c1 complex subunit 6, mitochondrial: HR
Cytochrome b-c1 complex subunit Rieske, mitochondrial: IS
Cytochrome b-c1 complex subunit 9: JT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AK
AB
BL
BC
CM
CD
DN
DE
EO
EF
FP
FG
GQ
GH
HR
HI
IS
IJ
JT
J - Membrane
-
We predict this structure to be a membrane protein.